TVTX icon

Travere Therapeutics

133 hedge funds and large institutions have $945M invested in Travere Therapeutics in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 43 increasing their positions, 49 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
133
Holders Change
-13
Holders Change %
-8.9%
% of All Funds
2.69%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
16
Increased
43
Reduced
49
Closed
28
Calls
$2.38M
Puts
$1.26M
Net Calls
+$1.12M
Net Calls Change
+$3.39M
Name Holding Trade Value Shares
Change
Shares
Change %
Qube Research & Technologies (QRT)
151
Qube Research & Technologies (QRT)
United Kingdom
-$330K -16,181 Closed
AI
152
ArchPoint Investors
Florida
-$303K -14,863 Closed
HSBC Holdings
153
HSBC Holdings
United Kingdom
-$254K -12,453 Closed
BBVA
154
Banco Bilbao Vizcaya Argentaria
Spain
-$204K -10,000 Closed
AIM
155
Aigen Investment Management
New York
-$204K -9,992 Closed
Acadian Asset Management
156
Acadian Asset Management
Massachusetts
-$198K -9,674 Closed
SO
157
STRS Ohio
Ohio
-$93K -4,600 Closed
Simplex Trading
158
Simplex Trading
Illinois
-$25K -1,236 Closed
CAN
159
Cetera Advisor Networks
California
-$20K -1,000 Closed
QI
160
QS Investors
New York
-$7K -337 Closed
UBS Group
161
UBS Group
Switzerland
-$5K -237 Closed